nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelarabine—ADA—brown adipose tissue—type 2 diabetes mellitus	0.04	0.292	CbGeAlD
Nelarabine—DGUOK—retina—type 2 diabetes mellitus	0.0127	0.0923	CbGeAlD
Nelarabine—DGUOK—cortex of kidney—type 2 diabetes mellitus	0.0102	0.0744	CbGeAlD
Nelarabine—DGUOK—adipose tissue—type 2 diabetes mellitus	0.00944	0.0689	CbGeAlD
Nelarabine—POLA1—retina—type 2 diabetes mellitus	0.00781	0.0569	CbGeAlD
Nelarabine—DGUOK—liver—type 2 diabetes mellitus	0.00662	0.0483	CbGeAlD
Nelarabine—ADA—cardiovascular system—type 2 diabetes mellitus	0.00613	0.0447	CbGeAlD
Nelarabine—POLA1—adipose tissue—type 2 diabetes mellitus	0.00583	0.0425	CbGeAlD
Nelarabine—DCK—islet of Langerhans—type 2 diabetes mellitus	0.00563	0.0411	CbGeAlD
Nelarabine—ADA—adipose tissue—type 2 diabetes mellitus	0.0054	0.0394	CbGeAlD
Nelarabine—DCK—retina—type 2 diabetes mellitus	0.00481	0.0351	CbGeAlD
Nelarabine—DCK—nephron tubule—type 2 diabetes mellitus	0.00453	0.0331	CbGeAlD
Nelarabine—POLA1—liver—type 2 diabetes mellitus	0.00409	0.0298	CbGeAlD
Nelarabine—S-Adenosylmethionine—MAT1A—type 2 diabetes mellitus	0.00398	0.173	CrCbGaD
Nelarabine—DCK—pancreas—type 2 diabetes mellitus	0.00396	0.0289	CbGeAlD
Nelarabine—DCK—cortex of kidney—type 2 diabetes mellitus	0.00388	0.0283	CbGeAlD
Nelarabine—Ribavirin—ENPP1—type 2 diabetes mellitus	0.00367	0.16	CrCbGaD
Nelarabine—DCK—adipose tissue—type 2 diabetes mellitus	0.00359	0.0262	CbGeAlD
Nelarabine—S-Adenosylmethionine—CBS—type 2 diabetes mellitus	0.00257	0.112	CrCbGaD
Nelarabine—DCK—liver—type 2 diabetes mellitus	0.00252	0.0184	CbGeAlD
Nelarabine—Azacitidine—DNMT1—type 2 diabetes mellitus	0.00192	0.0834	CrCbGaD
Nelarabine—Decitabine—DNMT1—type 2 diabetes mellitus	0.00187	0.0814	CrCbGaD
Nelarabine—Adenosine monophosphate—PRKAA1—type 2 diabetes mellitus	0.00163	0.0709	CrCbGaD
Nelarabine—Vidarabine—DPP4—type 2 diabetes mellitus	0.00162	0.0705	CrCbGaD
Nelarabine—Adenosine triphosphate—PRKAA1—type 2 diabetes mellitus	0.00141	0.0615	CrCbGaD
Nelarabine—Adenosine—DPP4—type 2 diabetes mellitus	0.00129	0.0563	CrCbGaD
Nelarabine—Adenosine triphosphate—ABCC8—type 2 diabetes mellitus	0.000833	0.0362	CrCbGaD
Nelarabine—Adenosine triphosphate—AKT1—type 2 diabetes mellitus	0.000668	0.0291	CrCbGaD
Nelarabine—Adenosine monophosphate—SRC—type 2 diabetes mellitus	0.000659	0.0287	CrCbGaD
Nelarabine—DGUOK—Metabolism—MTR—type 2 diabetes mellitus	0.000556	0.00244	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NAMPT—type 2 diabetes mellitus	0.000545	0.0024	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—HBA1—type 2 diabetes mellitus	0.000542	0.00238	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—LIPC—type 2 diabetes mellitus	0.000542	0.00238	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GCK—type 2 diabetes mellitus	0.000542	0.00238	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000538	0.00237	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	0.00053	0.00233	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000529	0.00232	CbGpPWpGaD
Nelarabine—POLA1—E2F transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000528	0.00232	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CETP—type 2 diabetes mellitus	0.000523	0.0023	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—FAS—type 2 diabetes mellitus	0.000517	0.00227	CbGpPWpGaD
Nelarabine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000505	0.000825	CcSEcCtD
Nelarabine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000505	0.000824	CcSEcCtD
Nelarabine—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000504	0.000824	CcSEcCtD
Nelarabine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000504	0.000823	CcSEcCtD
Nelarabine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000504	0.000822	CcSEcCtD
Nelarabine—Convulsion—Orlistat—type 2 diabetes mellitus	0.000503	0.000821	CcSEcCtD
Nelarabine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000502	0.00082	CcSEcCtD
Nelarabine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000502	0.00082	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000501	0.000819	CcSEcCtD
Nelarabine—Tremor—Metformin—type 2 diabetes mellitus	0.000501	0.000818	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—PPARA—type 2 diabetes mellitus	0.0005	0.0022	CbGpPWpGaD
Nelarabine—Chest pain—Valsartan—type 2 diabetes mellitus	0.0005	0.000816	CcSEcCtD
Nelarabine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.0005	0.000816	CcSEcCtD
Nelarabine—Myalgia—Valsartan—type 2 diabetes mellitus	0.0005	0.000816	CcSEcCtD
Nelarabine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000499	0.000815	CcSEcCtD
Nelarabine—ADA—Metabolism—BHMT—type 2 diabetes mellitus	0.000499	0.00219	CbGpPWpGaD
Nelarabine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000495	0.000808	CcSEcCtD
Nelarabine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000495	0.000808	CcSEcCtD
Nelarabine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000494	0.000807	CcSEcCtD
Nelarabine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000494	0.000806	CcSEcCtD
Nelarabine—Chest pain—Orlistat—type 2 diabetes mellitus	0.000494	0.000806	CcSEcCtD
Nelarabine—POLA1—Mitotic G1-G1/S phases—PPP2CA—type 2 diabetes mellitus	0.000494	0.00217	CbGpPWpGaD
Nelarabine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000493	0.000805	CcSEcCtD
Nelarabine—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000491	0.000802	CcSEcCtD
Nelarabine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000489	0.000798	CcSEcCtD
Nelarabine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000487	0.000796	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PSMD6—type 2 diabetes mellitus	0.000486	0.00214	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SREBF1—type 2 diabetes mellitus	0.000486	0.00214	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SNAP25—type 2 diabetes mellitus	0.000486	0.00214	CbGpPWpGaD
Nelarabine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000482	0.000787	CcSEcCtD
Nelarabine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.00048	0.000784	CcSEcCtD
Nelarabine—Vomiting—Glipizide—type 2 diabetes mellitus	0.00048	0.000784	CcSEcCtD
Nelarabine—Oedema—Valsartan—type 2 diabetes mellitus	0.000479	0.000782	CcSEcCtD
Nelarabine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000479	0.000782	CcSEcCtD
Nelarabine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000478	0.000781	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CTGF—type 2 diabetes mellitus	0.000477	0.0021	CbGpPWpGaD
Nelarabine—Infection—Valsartan—type 2 diabetes mellitus	0.000476	0.000777	CcSEcCtD
Nelarabine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000475	0.000776	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000475	0.000776	CcSEcCtD
Nelarabine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000475	0.000776	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—LEP—type 2 diabetes mellitus	0.000475	0.00209	CbGpPWpGaD
Nelarabine—Oedema—Orlistat—type 2 diabetes mellitus	0.000473	0.000773	CcSEcCtD
Nelarabine—Headache—Glipizide—type 2 diabetes mellitus	0.000473	0.000772	CcSEcCtD
Nelarabine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000473	0.000772	CcSEcCtD
Nelarabine—DGUOK—Metabolism—HMGCR—type 2 diabetes mellitus	0.000473	0.00208	CbGpPWpGaD
Nelarabine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000472	0.00077	CcSEcCtD
Nelarabine—Infection—Orlistat—type 2 diabetes mellitus	0.00047	0.000768	CcSEcCtD
Nelarabine—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.00047	0.000767	CcSEcCtD
Nelarabine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.00047	0.000767	CcSEcCtD
Nelarabine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000469	0.000766	CcSEcCtD
Nelarabine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000468	0.000765	CcSEcCtD
Nelarabine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000466	0.000761	CcSEcCtD
Nelarabine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000466	0.00076	CcSEcCtD
Nelarabine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000465	0.000759	CcSEcCtD
Nelarabine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000465	0.000759	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	0.000465	0.00204	CbGpPWpGaD
Nelarabine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000464	0.000758	CcSEcCtD
Nelarabine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000464	0.000758	CcSEcCtD
Nelarabine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000464	0.000757	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000462	0.00203	CbGpPWpGaD
Nelarabine—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000461	0.000752	CcSEcCtD
Nelarabine—DCK—Metabolism—BHMT—type 2 diabetes mellitus	0.00046	0.00202	CbGpPWpGaD
Nelarabine—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00046	0.00075	CcSEcCtD
Nelarabine—Back pain—Losartan—type 2 diabetes mellitus	0.000459	0.00075	CcSEcCtD
Nelarabine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000459	0.00075	CcSEcCtD
Nelarabine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000457	0.000746	CcSEcCtD
Nelarabine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000456	0.000744	CcSEcCtD
Nelarabine—Chest pain—Metformin—type 2 diabetes mellitus	0.000455	0.000743	CcSEcCtD
Nelarabine—Myalgia—Metformin—type 2 diabetes mellitus	0.000455	0.000743	CcSEcCtD
Nelarabine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000453	0.00074	CcSEcCtD
Nelarabine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000452	0.000737	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.00045	0.000735	CcSEcCtD
Nelarabine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.00045	0.000734	CcSEcCtD
Nelarabine—Nausea—Glipizide—type 2 diabetes mellitus	0.000448	0.000732	CcSEcCtD
Nelarabine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000448	0.000731	CcSEcCtD
Nelarabine—Hypotension—Valsartan—type 2 diabetes mellitus	0.000448	0.000731	CcSEcCtD
Nelarabine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000447	0.000731	CcSEcCtD
Nelarabine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000446	0.000729	CcSEcCtD
Nelarabine—Pain—Gliclazide—type 2 diabetes mellitus	0.000446	0.000728	CcSEcCtD
Nelarabine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000446	0.000728	CcSEcCtD
Nelarabine—Tremor—Losartan—type 2 diabetes mellitus	0.000445	0.000726	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000444	0.00195	CbGpPWpGaD
Nelarabine—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000443	0.000724	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—NOS2—type 2 diabetes mellitus	0.000442	0.00194	CbGpPWpGaD
Nelarabine—Headache—Glimepiride—type 2 diabetes mellitus	0.000441	0.00072	CcSEcCtD
Nelarabine—Cough—Irbesartan—type 2 diabetes mellitus	0.00044	0.000719	CcSEcCtD
Nelarabine—Headache—Sitagliptin—type 2 diabetes mellitus	0.00044	0.000718	CcSEcCtD
Nelarabine—DGUOK—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000439	0.00193	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000439	0.00193	CbGpPWpGaD
Nelarabine—Anaemia—Losartan—type 2 diabetes mellitus	0.000439	0.000717	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000437	0.000713	CcSEcCtD
Nelarabine—Oedema—Metformin—type 2 diabetes mellitus	0.000436	0.000712	CcSEcCtD
Nelarabine—ADA—Metabolism—PTGDS—type 2 diabetes mellitus	0.000436	0.00192	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AANAT—type 2 diabetes mellitus	0.000436	0.00192	CbGpPWpGaD
Nelarabine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000435	0.00071	CcSEcCtD
Nelarabine—Infection—Metformin—type 2 diabetes mellitus	0.000433	0.000708	CcSEcCtD
Nelarabine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000433	0.000708	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000431	0.000704	CcSEcCtD
Nelarabine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00043	0.000703	CcSEcCtD
Nelarabine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00043	0.000702	CcSEcCtD
Nelarabine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00043	0.000701	CcSEcCtD
Nelarabine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.00043	0.000701	CcSEcCtD
Nelarabine—Chest pain—Irbesartan—type 2 diabetes mellitus	0.00043	0.000701	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000428	0.00188	CbGpPWpGaD
Nelarabine—Insomnia—Orlistat—type 2 diabetes mellitus	0.000428	0.000699	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	0.000428	0.00188	CbGpPWpGaD
Nelarabine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000428	0.000699	CcSEcCtD
Nelarabine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000427	0.000698	CcSEcCtD
Nelarabine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000427	0.000698	CcSEcCtD
Nelarabine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000426	0.000696	CcSEcCtD
Nelarabine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000426	0.000696	CcSEcCtD
Nelarabine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000425	0.000694	CcSEcCtD
Nelarabine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000425	0.000694	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	0.000423	0.00186	CbGpPWpGaD
Nelarabine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000421	0.000688	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GCG—type 2 diabetes mellitus	0.000421	0.00185	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000421	0.00185	CbGpPWpGaD
Nelarabine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00042	0.000686	CcSEcCtD
Nelarabine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000418	0.000683	CcSEcCtD
Nelarabine—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000417	0.000681	CcSEcCtD
Nelarabine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000417	0.000681	CcSEcCtD
Nelarabine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000417	0.00068	CcSEcCtD
Nelarabine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000416	0.00068	CcSEcCtD
Nelarabine—Anorexia—Metformin—type 2 diabetes mellitus	0.000416	0.000679	CcSEcCtD
Nelarabine—Cough—Losartan—type 2 diabetes mellitus	0.000414	0.000677	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000414	0.000675	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—PPARG—type 2 diabetes mellitus	0.000414	0.00182	CbGpPWpGaD
Nelarabine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000413	0.000675	CcSEcCtD
Nelarabine—ADA—Metabolism—CDO1—type 2 diabetes mellitus	0.000413	0.00182	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPD2—type 2 diabetes mellitus	0.000413	0.00182	CbGpPWpGaD
Nelarabine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000412	0.000673	CcSEcCtD
Nelarabine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000412	0.000673	CcSEcCtD
Nelarabine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000412	0.000672	CcSEcCtD
Nelarabine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000412	0.000672	CcSEcCtD
Nelarabine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00041	0.000669	CcSEcCtD
Nelarabine—Constipation—Valsartan—type 2 diabetes mellitus	0.00041	0.000669	CcSEcCtD
Nelarabine—Infection—Irbesartan—type 2 diabetes mellitus	0.000409	0.000668	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000409	0.000667	CcSEcCtD
Nelarabine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000408	0.000667	CcSEcCtD
Nelarabine—Hypotension—Metformin—type 2 diabetes mellitus	0.000408	0.000666	CcSEcCtD
Nelarabine—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000407	0.000665	CcSEcCtD
Nelarabine—Pain—Orlistat—type 2 diabetes mellitus	0.000405	0.000661	CcSEcCtD
Nelarabine—Arthralgia—Losartan—type 2 diabetes mellitus	0.000404	0.00066	CcSEcCtD
Nelarabine—Myalgia—Losartan—type 2 diabetes mellitus	0.000404	0.00066	CcSEcCtD
Nelarabine—Chest pain—Losartan—type 2 diabetes mellitus	0.000404	0.00066	CcSEcCtD
Nelarabine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000404	0.00066	CcSEcCtD
Nelarabine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000404	0.000659	CcSEcCtD
Nelarabine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000403	0.000658	CcSEcCtD
Nelarabine—DCK—Metabolism—AANAT—type 2 diabetes mellitus	0.000402	0.00177	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGDS—type 2 diabetes mellitus	0.000402	0.00177	CbGpPWpGaD
Nelarabine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000399	0.000651	CcSEcCtD
Nelarabine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000398	0.00065	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000398	0.000649	CcSEcCtD
Nelarabine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000397	0.000649	CcSEcCtD
Nelarabine—ADA—Metabolism—AK1—type 2 diabetes mellitus	0.000394	0.00173	CbGpPWpGaD
Nelarabine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000392	0.000641	CcSEcCtD
Nelarabine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000392	0.00064	CcSEcCtD
Nelarabine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000392	0.00064	CcSEcCtD
Nelarabine—Confusional state—Losartan—type 2 diabetes mellitus	0.000391	0.000638	CcSEcCtD
Nelarabine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00039	0.000637	CcSEcCtD
Nelarabine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000389	0.000635	CcSEcCtD
Nelarabine—Somnolence—Metformin—type 2 diabetes mellitus	0.000388	0.000633	CcSEcCtD
Nelarabine—Oedema—Losartan—type 2 diabetes mellitus	0.000387	0.000633	CcSEcCtD
Nelarabine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000387	0.000632	CcSEcCtD
Nelarabine—Infection—Losartan—type 2 diabetes mellitus	0.000385	0.000629	CcSEcCtD
Nelarabine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000385	0.000628	CcSEcCtD
Nelarabine—Tremor—Ramipril—type 2 diabetes mellitus	0.000381	0.000623	CcSEcCtD
Nelarabine—DCK—Metabolism—CDO1—type 2 diabetes mellitus	0.000381	0.00168	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPD2—type 2 diabetes mellitus	0.000381	0.00168	CbGpPWpGaD
Nelarabine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00038	0.000621	CcSEcCtD
Nelarabine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000379	0.00062	CcSEcCtD
Nelarabine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000379	0.000619	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PSMD6—type 2 diabetes mellitus	0.000379	0.00167	CbGpPWpGaD
Nelarabine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000379	0.000618	CcSEcCtD
Nelarabine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000377	0.000616	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000377	0.000615	CcSEcCtD
Nelarabine—Fatigue—Metformin—type 2 diabetes mellitus	0.000376	0.000614	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000375	0.000613	CcSEcCtD
Nelarabine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000374	0.000611	CcSEcCtD
Nelarabine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000374	0.000611	CcSEcCtD
Nelarabine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000374	0.000611	CcSEcCtD
Nelarabine—Constipation—Metformin—type 2 diabetes mellitus	0.000373	0.000609	CcSEcCtD
Nelarabine—ADA—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	0.000373	0.00164	CbGpPWpGaD
Nelarabine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.00037	0.000604	CcSEcCtD
Nelarabine—Anorexia—Losartan—type 2 diabetes mellitus	0.000369	0.000603	CcSEcCtD
Nelarabine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000369	0.000603	CcSEcCtD
Nelarabine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000367	0.000599	CcSEcCtD
Nelarabine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000366	0.000598	CcSEcCtD
Nelarabine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000364	0.000595	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	0.000364	0.0016	CbGpPWpGaD
Nelarabine—Headache—Glyburide—type 2 diabetes mellitus	0.000364	0.000594	CcSEcCtD
Nelarabine—DCK—Metabolism—AK1—type 2 diabetes mellitus	0.000364	0.0016	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MAT1A—type 2 diabetes mellitus	0.000364	0.0016	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000364	0.0016	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GNB3—type 2 diabetes mellitus	0.000363	0.0016	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000363	0.0016	CbGpPWpGaD
Nelarabine—Hypotension—Losartan—type 2 diabetes mellitus	0.000362	0.000591	CcSEcCtD
Nelarabine—DGUOK—Metabolism—HMOX1—type 2 diabetes mellitus	0.000361	0.00159	CbGpPWpGaD
Nelarabine—S-Adenosylmethionine—CYP2E1—type 2 diabetes mellitus	0.00036	0.0157	CrCbGaD
Nelarabine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00036	0.000587	CcSEcCtD
Nelarabine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000358	0.000584	CcSEcCtD
Nelarabine—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000358	0.000584	CcSEcCtD
Nelarabine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000357	0.000583	CcSEcCtD
Nelarabine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000357	0.000583	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CAT—type 2 diabetes mellitus	0.000357	0.00157	CbGpPWpGaD
Nelarabine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000355	0.00058	CcSEcCtD
Nelarabine—Cough—Ramipril—type 2 diabetes mellitus	0.000355	0.00058	CcSEcCtD
Nelarabine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000355	0.00058	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000353	0.000577	CcSEcCtD
Nelarabine—Convulsion—Ramipril—type 2 diabetes mellitus	0.000353	0.000576	CcSEcCtD
Nelarabine—Pain—Irbesartan—type 2 diabetes mellitus	0.000352	0.000575	CcSEcCtD
Nelarabine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000352	0.000575	CcSEcCtD
Nelarabine—ADA—Metabolism—HBA2—type 2 diabetes mellitus	0.000351	0.00154	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ND1—type 2 diabetes mellitus	0.000351	0.00154	CbGpPWpGaD
Nelarabine—ADA—Metabolism—G6PC—type 2 diabetes mellitus	0.000351	0.00154	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ENPP1—type 2 diabetes mellitus	0.000351	0.00154	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000351	0.00154	CbGpPWpGaD
Nelarabine—Insomnia—Losartan—type 2 diabetes mellitus	0.00035	0.000572	CcSEcCtD
Nelarabine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000348	0.000568	CcSEcCtD
Nelarabine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000347	0.000566	CcSEcCtD
Nelarabine—Chest pain—Ramipril—type 2 diabetes mellitus	0.000347	0.000566	CcSEcCtD
Nelarabine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000347	0.000566	CcSEcCtD
Nelarabine—DGUOK—Metabolism—APOB—type 2 diabetes mellitus	0.000346	0.00152	CbGpPWpGaD
Nelarabine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000345	0.000564	CcSEcCtD
Nelarabine—Nausea—Glyburide—type 2 diabetes mellitus	0.000345	0.000563	CcSEcCtD
Nelarabine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000345	0.000563	CcSEcCtD
Nelarabine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000345	0.000563	CcSEcCtD
Nelarabine—Somnolence—Losartan—type 2 diabetes mellitus	0.000344	0.000563	CcSEcCtD
Nelarabine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000344	0.000561	CcSEcCtD
Nelarabine—ADA—Metabolism—GCGR—type 2 diabetes mellitus	0.00034	0.0015	CbGpPWpGaD
Nelarabine—Asthenia—Orlistat—type 2 diabetes mellitus	0.00034	0.000555	CcSEcCtD
Nelarabine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000339	0.000554	CcSEcCtD
Nelarabine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000337	0.00055	CcSEcCtD
Nelarabine—DGUOK—Metabolism—GSTM1—type 2 diabetes mellitus	0.000337	0.00148	CbGpPWpGaD
Nelarabine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000337	0.00055	CcSEcCtD
Nelarabine—DCK—Metabolism—MAT1A—type 2 diabetes mellitus	0.000336	0.00148	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000336	0.00148	CbGpPWpGaD
Nelarabine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000335	0.000547	CcSEcCtD
Nelarabine—Fatigue—Losartan—type 2 diabetes mellitus	0.000334	0.000546	CcSEcCtD
Nelarabine—Oedema—Ramipril—type 2 diabetes mellitus	0.000332	0.000543	CcSEcCtD
Nelarabine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000332	0.000541	CcSEcCtD
Nelarabine—Pain—Losartan—type 2 diabetes mellitus	0.000331	0.000541	CcSEcCtD
Nelarabine—Constipation—Losartan—type 2 diabetes mellitus	0.000331	0.000541	CcSEcCtD
Nelarabine—DGUOK—Metabolism—LPL—type 2 diabetes mellitus	0.000331	0.00145	CbGpPWpGaD
Nelarabine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000328	0.000535	CcSEcCtD
Nelarabine—Headache—Gliclazide—type 2 diabetes mellitus	0.000327	0.000533	CcSEcCtD
Nelarabine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000326	0.000532	CcSEcCtD
Nelarabine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000325	0.000532	CcSEcCtD
Nelarabine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000325	0.000532	CcSEcCtD
Nelarabine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000325	0.000531	CcSEcCtD
Nelarabine—DCK—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000324	0.00142	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ENPP1—type 2 diabetes mellitus	0.000324	0.00142	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HBA2—type 2 diabetes mellitus	0.000324	0.00142	CbGpPWpGaD
Nelarabine—DCK—Metabolism—G6PC—type 2 diabetes mellitus	0.000324	0.00142	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ND1—type 2 diabetes mellitus	0.000324	0.00142	CbGpPWpGaD
Nelarabine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000324	0.000529	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ADCY5—type 2 diabetes mellitus	0.000324	0.00142	CbGpPWpGaD
Nelarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—type 2 diabetes mellitus	0.000323	0.00142	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—GPX1—type 2 diabetes mellitus	0.000322	0.00142	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYTB—type 2 diabetes mellitus	0.000321	0.00141	CbGpPWpGaD
Nelarabine—ADA—Metabolism—OXCT1—type 2 diabetes mellitus	0.000321	0.00141	CbGpPWpGaD
Nelarabine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000319	0.000521	CcSEcCtD
Nelarabine—Adenosine triphosphate—ABCC2—type 2 diabetes mellitus	0.000317	0.0138	CrCbGaD
Nelarabine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000317	0.000517	CcSEcCtD
Nelarabine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000317	0.000517	CcSEcCtD
Nelarabine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000317	0.000517	CcSEcCtD
Nelarabine—DGUOK—Metabolism—CD36—type 2 diabetes mellitus	0.000314	0.00138	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GCGR—type 2 diabetes mellitus	0.000314	0.00138	CbGpPWpGaD
Nelarabine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000313	0.000511	CcSEcCtD
Nelarabine—ADA—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000313	0.00138	CbGpPWpGaD
Nelarabine—Asthenia—Metformin—type 2 diabetes mellitus	0.000313	0.000511	CcSEcCtD
Nelarabine—Hypotension—Ramipril—type 2 diabetes mellitus	0.00031	0.000507	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PPP2CA—type 2 diabetes mellitus	0.00031	0.00136	CbGpPWpGaD
Nelarabine—Nausea—Gliclazide—type 2 diabetes mellitus	0.00031	0.000506	CcSEcCtD
Nelarabine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000306	0.0005	CcSEcCtD
Nelarabine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000306	0.0005	CcSEcCtD
Nelarabine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000305	0.000497	CcSEcCtD
Nelarabine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000303	0.000494	CcSEcCtD
Nelarabine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000301	0.000492	CcSEcCtD
Nelarabine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000301	0.000491	CcSEcCtD
Nelarabine—Headache—Valsartan—type 2 diabetes mellitus	0.0003	0.00049	CcSEcCtD
Nelarabine—ADA—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000299	0.00131	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ACACA—type 2 diabetes mellitus	0.000299	0.00131	CbGpPWpGaD
Nelarabine—ADA—Metabolism—STAR—type 2 diabetes mellitus	0.000299	0.00131	CbGpPWpGaD
Nelarabine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000299	0.000487	CcSEcCtD
Nelarabine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000298	0.000487	CcSEcCtD
Nelarabine—DGUOK—Metabolism—MTHFR—type 2 diabetes mellitus	0.000298	0.00131	CbGpPWpGaD
Nelarabine—Headache—Orlistat—type 2 diabetes mellitus	0.000297	0.000484	CcSEcCtD
Nelarabine—DCK—Metabolism—OXCT1—type 2 diabetes mellitus	0.000296	0.0013	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYTB—type 2 diabetes mellitus	0.000296	0.0013	CbGpPWpGaD
Nelarabine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000296	0.000484	CcSEcCtD
Nelarabine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000295	0.000482	CcSEcCtD
Nelarabine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000295	0.000482	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PPARA—type 2 diabetes mellitus	0.000292	0.00128	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000289	0.00127	CbGpPWpGaD
Nelarabine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000289	0.000472	CcSEcCtD
Nelarabine—Dizziness—Metformin—type 2 diabetes mellitus	0.000289	0.000471	CcSEcCtD
Nelarabine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000287	0.000468	CcSEcCtD
Nelarabine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000286	0.000468	CcSEcCtD
Nelarabine—ADA—Metabolism—ABCC8—type 2 diabetes mellitus	0.000286	0.00126	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CBS—type 2 diabetes mellitus	0.000286	0.00126	CbGpPWpGaD
Nelarabine—Nausea—Valsartan—type 2 diabetes mellitus	0.000285	0.000465	CcSEcCtD
Nelarabine—Constipation—Ramipril—type 2 diabetes mellitus	0.000284	0.000464	CcSEcCtD
Nelarabine—POLA1—Cell Cycle, Mitotic—PSMD6—type 2 diabetes mellitus	0.000284	0.00125	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AGT—type 2 diabetes mellitus	0.000283	0.00124	CbGpPWpGaD
Nelarabine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000282	0.00046	CcSEcCtD
Nelarabine—Nausea—Orlistat—type 2 diabetes mellitus	0.000281	0.000459	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	0.000281	0.00123	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—CALM1—type 2 diabetes mellitus	0.000278	0.00122	CbGpPWpGaD
Nelarabine—Asthenia—Losartan—type 2 diabetes mellitus	0.000278	0.000454	CcSEcCtD
Nelarabine—Vomiting—Metformin—type 2 diabetes mellitus	0.000277	0.000453	CcSEcCtD
Nelarabine—DGUOK—Metabolism—APOE—type 2 diabetes mellitus	0.000277	0.00122	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	0.000276	0.00121	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000276	0.00121	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000276	0.00121	CbGpPWpGaD
Nelarabine—DCK—Metabolism—STAR—type 2 diabetes mellitus	0.000276	0.00121	CbGpPWpGaD
Nelarabine—ADA—Metabolism—COX2—type 2 diabetes mellitus	0.000276	0.00121	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ACACA—type 2 diabetes mellitus	0.000276	0.00121	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—APOA1—type 2 diabetes mellitus	0.000274	0.0012	CbGpPWpGaD
Nelarabine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000274	0.000447	CcSEcCtD
Nelarabine—Headache—Metformin—type 2 diabetes mellitus	0.000273	0.000446	CcSEcCtD
Nelarabine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000272	0.000445	CcSEcCtD
Nelarabine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000272	0.000444	CcSEcCtD
Nelarabine—ADA—Metabolism—NCOA6—type 2 diabetes mellitus	0.000271	0.00119	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000266	0.00117	CbGpPWpGaD
Nelarabine—ADA—Metabolism—UCP2—type 2 diabetes mellitus	0.000266	0.00117	CbGpPWpGaD
Nelarabine—ADA—Metabolism—UCP3—type 2 diabetes mellitus	0.000266	0.00117	CbGpPWpGaD
Nelarabine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000265	0.000433	CcSEcCtD
Nelarabine—DCK—Metabolism—ABCC8—type 2 diabetes mellitus	0.000264	0.00116	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CBS—type 2 diabetes mellitus	0.000264	0.00116	CbGpPWpGaD
Nelarabine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000263	0.000429	CcSEcCtD
Nelarabine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000263	0.000429	CcSEcCtD
Nelarabine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000262	0.000428	CcSEcCtD
Nelarabine—Nausea—Metformin—type 2 diabetes mellitus	0.000259	0.000423	CcSEcCtD
Nelarabine—Headache—Irbesartan—type 2 diabetes mellitus	0.000258	0.000421	CcSEcCtD
Nelarabine—Dizziness—Losartan—type 2 diabetes mellitus	0.000256	0.000418	CcSEcCtD
Nelarabine—DCK—Metabolism—COX2—type 2 diabetes mellitus	0.000254	0.00112	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000254	0.00112	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PSMD6—type 2 diabetes mellitus	0.000254	0.00111	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PCK1—type 2 diabetes mellitus	0.00025	0.0011	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NCOA6—type 2 diabetes mellitus	0.00025	0.0011	CbGpPWpGaD
Nelarabine—Vomiting—Losartan—type 2 diabetes mellitus	0.000246	0.000402	CcSEcCtD
Nelarabine—DCK—Metabolism—UCP2—type 2 diabetes mellitus	0.000246	0.00108	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000246	0.00108	CbGpPWpGaD
Nelarabine—DCK—Metabolism—UCP3—type 2 diabetes mellitus	0.000246	0.00108	CbGpPWpGaD
Nelarabine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000245	0.000399	CcSEcCtD
Nelarabine—Headache—Losartan—type 2 diabetes mellitus	0.000243	0.000396	CcSEcCtD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PPP2CA—type 2 diabetes mellitus	0.000242	0.00106	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—PPARG—type 2 diabetes mellitus	0.000241	0.00106	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	0.000241	0.00106	CbGpPWpGaD
Nelarabine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000238	0.000389	CcSEcCtD
Nelarabine—DGUOK—Metabolism—INS—type 2 diabetes mellitus	0.000237	0.00104	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HK1—type 2 diabetes mellitus	0.000234	0.00103	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CCND2—type 2 diabetes mellitus	0.000231	0.00102	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PCK1—type 2 diabetes mellitus	0.000231	0.00102	CbGpPWpGaD
Nelarabine—Nausea—Losartan—type 2 diabetes mellitus	0.00023	0.000376	CcSEcCtD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	0.000229	0.00101	CbGpPWpGaD
Nelarabine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000227	0.000371	CcSEcCtD
Nelarabine—ADA—Metabolism—GCKR—type 2 diabetes mellitus	0.000226	0.000995	CbGpPWpGaD
Nelarabine—ADA—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000226	0.000995	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000226	0.000995	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LPA—type 2 diabetes mellitus	0.000226	0.000995	CbGpPWpGaD
Nelarabine—Dizziness—Ramipril—type 2 diabetes mellitus	0.00022	0.000359	CcSEcCtD
Nelarabine—DGUOK—Metabolism—ALB—type 2 diabetes mellitus	0.000217	0.000954	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALDOB—type 2 diabetes mellitus	0.000217	0.000954	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HK1—type 2 diabetes mellitus	0.000216	0.000951	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	0.000212	0.000934	CbGpPWpGaD
Nelarabine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000211	0.000345	CcSEcCtD
Nelarabine—DCK—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000209	0.000918	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GCKR—type 2 diabetes mellitus	0.000209	0.000918	CbGpPWpGaD
Nelarabine—DCK—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000209	0.000918	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LPA—type 2 diabetes mellitus	0.000209	0.000918	CbGpPWpGaD
Nelarabine—Headache—Ramipril—type 2 diabetes mellitus	0.000208	0.00034	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PIK3R1—type 2 diabetes mellitus	0.000208	0.000912	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—NOS3—type 2 diabetes mellitus	0.000208	0.000912	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2B—type 2 diabetes mellitus	0.000207	0.000911	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CCND2—type 2 diabetes mellitus	0.000207	0.000908	CbGpPWpGaD
Nelarabine—POLA1—Mitotic M-M/G1 phases—PRKCB—type 2 diabetes mellitus	0.000204	0.000896	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GLP1R—type 2 diabetes mellitus	0.000202	0.000887	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALDOB—type 2 diabetes mellitus	0.0002	0.00088	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	0.000199	0.000873	CbGpPWpGaD
Nelarabine—Nausea—Ramipril—type 2 diabetes mellitus	0.000197	0.000322	CcSEcCtD
Nelarabine—DGUOK—Metabolism—PTGS2—type 2 diabetes mellitus	0.00019	0.000834	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000188	0.000828	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GLP1R—type 2 diabetes mellitus	0.000186	0.000818	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2B—type 2 diabetes mellitus	0.000185	0.000814	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	0.000185	0.000814	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTR—type 2 diabetes mellitus	0.000184	0.000811	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CPT1A—type 2 diabetes mellitus	0.000184	0.000811	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PPP2CA—type 2 diabetes mellitus	0.000181	0.000796	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NAMPT—type 2 diabetes mellitus	0.000181	0.000795	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	0.00018	0.000792	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HBA1—type 2 diabetes mellitus	0.00018	0.00079	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LIPC—type 2 diabetes mellitus	0.00018	0.00079	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GCK—type 2 diabetes mellitus	0.00018	0.00079	CbGpPWpGaD
Nelarabine—Cytarabine—CYP3A4—type 2 diabetes mellitus	0.000179	0.00779	CrCbGaD
Nelarabine—ADA—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000179	0.000785	CbGpPWpGaD
Nelarabine—ADA—Circadian rythm related genes—IL6—type 2 diabetes mellitus	0.000177	0.000779	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000175	0.000771	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000174	0.000764	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CETP—type 2 diabetes mellitus	0.000173	0.000762	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTR—type 2 diabetes mellitus	0.00017	0.000748	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CPT1A—type 2 diabetes mellitus	0.00017	0.000748	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NAMPT—type 2 diabetes mellitus	0.000167	0.000734	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HBA1—type 2 diabetes mellitus	0.000166	0.000729	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LIPC—type 2 diabetes mellitus	0.000166	0.000729	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GCK—type 2 diabetes mellitus	0.000166	0.000729	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	0.000165	0.000727	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000165	0.000725	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	0.000162	0.000713	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000162	0.000712	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PPP2CA—type 2 diabetes mellitus	0.000162	0.000711	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SREBF1—type 2 diabetes mellitus	0.000161	0.000709	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SNAP25—type 2 diabetes mellitus	0.000161	0.000709	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PSMD6—type 2 diabetes mellitus	0.000161	0.000709	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CETP—type 2 diabetes mellitus	0.00016	0.000704	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CTGF—type 2 diabetes mellitus	0.000158	0.000696	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMGCR—type 2 diabetes mellitus	0.000157	0.00069	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	0.000155	0.000679	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000154	0.000675	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—PRKCB—type 2 diabetes mellitus	0.000153	0.00067	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SREBF1—type 2 diabetes mellitus	0.000149	0.000654	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SNAP25—type 2 diabetes mellitus	0.000149	0.000654	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PSMD6—type 2 diabetes mellitus	0.000149	0.000654	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000147	0.000648	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CTGF—type 2 diabetes mellitus	0.000146	0.000642	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000146	0.000641	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000146	0.000641	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMGCR—type 2 diabetes mellitus	0.000145	0.000636	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000142	0.000625	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000142	0.000623	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GCG—type 2 diabetes mellitus	0.00014	0.000615	CbGpPWpGaD
Nelarabine—ADA—Metabolism—SLC2A4—type 2 diabetes mellitus	0.00014	0.000615	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—PRKCB—type 2 diabetes mellitus	0.000136	0.000599	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000136	0.000598	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000135	0.000592	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000135	0.000592	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000131	0.000577	CbGpPWpGaD
Nelarabine—DCK—Metabolism—SLC2A4—type 2 diabetes mellitus	0.000129	0.000567	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GCG—type 2 diabetes mellitus	0.000129	0.000567	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GNB3—type 2 diabetes mellitus	0.000121	0.00053	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000121	0.00053	CbGpPWpGaD
Nelarabine—ADA—Metabolism—HMOX1—type 2 diabetes mellitus	0.00012	0.000527	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—type 2 diabetes mellitus	0.000119	0.000521	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CAT—type 2 diabetes mellitus	0.000118	0.00052	CbGpPWpGaD
Nelarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	0.000115	0.000506	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOB—type 2 diabetes mellitus	0.000115	0.000505	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GSTM1—type 2 diabetes mellitus	0.000112	0.000491	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GNB3—type 2 diabetes mellitus	0.000111	0.000489	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000111	0.000489	CbGpPWpGaD
Nelarabine—DCK—Metabolism—HMOX1—type 2 diabetes mellitus	0.000111	0.000487	CbGpPWpGaD
Nelarabine—ADA—Metabolism—LPL—type 2 diabetes mellitus	0.00011	0.000482	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CAT—type 2 diabetes mellitus	0.000109	0.00048	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ADCY5—type 2 diabetes mellitus	0.000107	0.000472	CbGpPWpGaD
Nelarabine—ADA—Metabolism—GPX1—type 2 diabetes mellitus	0.000107	0.000471	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOB—type 2 diabetes mellitus	0.000106	0.000466	CbGpPWpGaD
Nelarabine—POLA1—Cell Cycle—CDKN2A—type 2 diabetes mellitus	0.000106	0.000466	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CD36—type 2 diabetes mellitus	0.000104	0.000458	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GSTM1—type 2 diabetes mellitus	0.000103	0.000453	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPP2CA—type 2 diabetes mellitus	0.000103	0.000452	CbGpPWpGaD
Nelarabine—DCK—Metabolism—LPL—type 2 diabetes mellitus	0.000101	0.000445	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ADCY5—type 2 diabetes mellitus	9.91e-05	0.000436	CbGpPWpGaD
Nelarabine—ADA—Metabolism—MTHFR—type 2 diabetes mellitus	9.88e-05	0.000434	CbGpPWpGaD
Nelarabine—DCK—Metabolism—GPX1—type 2 diabetes mellitus	9.88e-05	0.000434	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARA—type 2 diabetes mellitus	9.69e-05	0.000426	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CD36—type 2 diabetes mellitus	9.62e-05	0.000423	CbGpPWpGaD
Nelarabine—DGUOK—Metabolism—AKT1—type 2 diabetes mellitus	9.54e-05	0.000419	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPP2CA—type 2 diabetes mellitus	9.5e-05	0.000418	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AGT—type 2 diabetes mellitus	9.39e-05	0.000413	CbGpPWpGaD
Nelarabine—ADA—Metabolism—CALM1—type 2 diabetes mellitus	9.23e-05	0.000406	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOE—type 2 diabetes mellitus	9.2e-05	0.000404	CbGpPWpGaD
Nelarabine—DCK—Metabolism—MTHFR—type 2 diabetes mellitus	9.12e-05	0.000401	CbGpPWpGaD
Nelarabine—ADA—Metabolism—APOA1—type 2 diabetes mellitus	9.09e-05	0.0004	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARA—type 2 diabetes mellitus	8.94e-05	0.000393	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AGT—type 2 diabetes mellitus	8.66e-05	0.000381	CbGpPWpGaD
Nelarabine—DCK—Metabolism—CALM1—type 2 diabetes mellitus	8.52e-05	0.000374	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOE—type 2 diabetes mellitus	8.49e-05	0.000373	CbGpPWpGaD
Nelarabine—DCK—Metabolism—APOA1—type 2 diabetes mellitus	8.39e-05	0.000369	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PPARG—type 2 diabetes mellitus	8.01e-05	0.000352	CbGpPWpGaD
Nelarabine—ADA—Metabolism—INS—type 2 diabetes mellitus	7.86e-05	0.000345	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PPARG—type 2 diabetes mellitus	7.39e-05	0.000325	CbGpPWpGaD
Nelarabine—DCK—Metabolism—INS—type 2 diabetes mellitus	7.25e-05	0.000319	CbGpPWpGaD
Nelarabine—ADA—Metabolism—ALB—type 2 diabetes mellitus	7.2e-05	0.000317	CbGpPWpGaD
Nelarabine—ADA—Metabolism—NOS3—type 2 diabetes mellitus	6.89e-05	0.000303	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PIK3R1—type 2 diabetes mellitus	6.89e-05	0.000303	CbGpPWpGaD
Nelarabine—DCK—Metabolism—ALB—type 2 diabetes mellitus	6.65e-05	0.000292	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PIK3R1—type 2 diabetes mellitus	6.36e-05	0.000279	CbGpPWpGaD
Nelarabine—DCK—Metabolism—NOS3—type 2 diabetes mellitus	6.36e-05	0.000279	CbGpPWpGaD
Nelarabine—ADA—Metabolism—PTGS2—type 2 diabetes mellitus	6.3e-05	0.000277	CbGpPWpGaD
Nelarabine—DCK—Metabolism—PTGS2—type 2 diabetes mellitus	5.82e-05	0.000256	CbGpPWpGaD
Nelarabine—ADA—Metabolism—AKT1—type 2 diabetes mellitus	3.17e-05	0.000139	CbGpPWpGaD
Nelarabine—DCK—Metabolism—AKT1—type 2 diabetes mellitus	2.92e-05	0.000128	CbGpPWpGaD
